IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
Inventiva S.A.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026
$2.98+0.04 (+1.36%)
Close on Oct 19, 2026
Inventiva statistics
Financials through Jun 30, 2026, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Inventiva | Industry median |
|---|---|---|
| Market Cap | €514.47M | €878.09M |
| Enterprise Value | €348.34M | €706.41M |
| PS Ratio | 114.76 | 6.85 |
Enterprise value
| Measure | Inventiva | Industry median |
|---|---|---|
| EV / Sales | 77.70 | 3.86 |
Income (trailing twelve months)
| Measure | Inventiva | Industry median |
|---|---|---|
| Revenue | €4.48M | €465.66M |
| Operating Income | -€141.01M | -€54.01M |
| EBITDA | -€141.01M | -€42.85M |
| EPS (Diluted) | -1.90 EUR | -0.55 EUR |
Margins
| Measure | Inventiva | Industry median |
|---|---|---|
| Operating Margin | -3145.5% | -33.2% |
| EBITDA Margin | -3145.5% | -28.6% |
Returns
| Measure | Inventiva | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -75.6% | -23.8% |
Growth
| Measure | Inventiva | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -51.3% | -1.08% |
| Revenue Growth (3Y CAGR) | -28.3% | 1.61% |
| Revenue Growth (5Y CAGR) | 64.5% | 14.0% |
Balance sheet
| Measure | Inventiva | Industry median |
|---|---|---|
| Cash & Short-Term Investments | €166.13M | €199.29M |
| Net Cash (Debt) | €166.13M | €111.50M |
| Net Cash Per Share | 0.86 EUR | 1.53 EUR |
| Working Capital | €181.38M | €119.55M |
Financial position
| Measure | Inventiva | Industry median |
|---|---|---|
| Current Ratio | 3.81 | 3.49 |
| Quick Ratio | 2.63 | 1.51 |
| Interest Coverage | -0.65 | -0.71 |
Cash flow (trailing twelve months)
| Measure | Inventiva | Industry median |
|---|---|---|
| Operating Cash Flow | -€104.88M | -€42.16M |
Efficiency
| Measure | Inventiva | Industry median |
|---|---|---|
| Asset Turnover | 0.02 | 0.31 |
| Revenue Per Employee | €58.22K | €855.98K |
| Employee Count | 77 | 304 |
Dividends and yields
| Measure | Inventiva | Industry median |
|---|---|---|
| Buyback Yield | -40.1% | -11.4% |
| Shareholder Yield | -40.1% | -11.4% |
Shares
| Measure | Inventiva | Industry median |
|---|---|---|
| Shares Outstanding | 193,237,000 | 99,540,150 |
| Shares Change (YoY) | 212.5% | 5.61% |
| Float | 145,543,000 | 78,574,400 |
| Shares Held by Insiders | 24.7% | 9.05% |
| Shares Held by Institutions | 45.2% | 13.8% |
Taxes
| Measure | Inventiva | Industry median |
|---|---|---|
| Income Tax | €22.00K | €80.00K |
Scores
| Measure | Inventiva | Industry median |
|---|---|---|
| Altman Z-Score | 0.64 | 1.13 |
Calculated by StockData from Inventiva's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.